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Telomerase activity controls telomere length, and this plays an important role in stem cells, aging and
tumors. Antioxidant was shown to protect telomerase activity in normal cells but inhibit that in cancer
cells, but the underlying mechanism is elusive. Here we found that 7721 hepatoma cells held a higher
redox homeostasis threshold than L02 normal liver cells which caused 7721 cells to have a higher de-
mand for ROS; MnSOD over-expression in 7721 decreased endogenous reactive oxygen species (ROS) and
inhibited telomerase activity; Akt phosphorylation inhibitor and NAC both inhibited 7721 telomerase
activity. The over-elimination of ROS by NAC resulted in the inhibition of Akt pathway. Our results
suggest that ROS is involved in the regulation of cancer telomerase activity through Akt pathway. The
different intracellular redox homeostasis and antioxidant system in normal cells and tumor cells may be
the cause of the opposite effect on telomerase activity in response to NAC treatment. Our results provide
a theoretical base of using antioxidants selectively inhibit cancer telomerase activity. Findings of the
present study may provide insights into novel approaches for cancer treatment.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Telomeres are nucleoprotein structures, located at the ends of
chromosomes and are subject to shortening at each cycle of cell
division, which forces human primary cells to stop dividing when
a critical minimum telomere length is reached [1,2]. They are
synthesized by telomerase consisting of a reverse transcriptase
catalytic subunit (TERT) and an RNA template subunit (TERC) [3,4].
Telomerase activity is closely related to aging and tumorigesis. It is
generally inhibited in normal cells but highly activated in tumor
cells. The differential expression of the telomerase enzyme in
normal and cancer cells have led to the evolution of tumor speciﬁc
anti-telomerase approaches which inhibit the telomerase enzyme
activity so as to destabilize and shorten the telomeres, leading to
senescence in cancer cells.
In numerous studies on telomerase regulation mechanism, the
relationship between oxidative stress and telomerase has suc-
cessfully attracted worldwide attention. As reactive oxygen species
(ROS) are particularly injurious toward the G-rich sequences of
telomeres [5], ROS scavengers, also called antioxidants, have been
used in protecting telomere and slowing the aging process of cells
for many years [2,6,7]. However, in tumor cells, antioxidantsB.V. This is an open access article uexhibit quite the opposite effect. Many drugs which have been
reported to possess antioxidant properties could inhibit tumor
telomerase activity, promoting telomere shortening and provoking
tumor cell apoptosis [8–12]. To the best of our knowledge, there is
no research has explained the reason why antioxidants have dif-
ferent effects on telomerase activity of normal and tumor cells,
and the present study is trying to explore the potential mechanism
underlying this phenomenon.
Antioxidants such as NAC directly affect both ROS levels and
the intracellular redox state (REDST). The intracellular oxidative
damage/antioxidant defense is maintained at a relatively constant
state relying on the combinatory effects of a variety of oxidizing
substances, antioxidants and other related enzymatic systems.
Redox disorders would cause redox balance to be shifted to the
direction of oxidation or reduction, leading to excessive ROS pro-
duction or elimination. Both excessive and insufﬁcient amount of
ROS will bring about bad effect on health, as ROS are no longer
viewed just as a toxic by-product of mitochondrial respiration, but
a double-edge sword and play an important role in numerous
cellular processes. There is a growing body of evidence have in-
dicated that ROS may be an essential element required for reg-
ulating a myriad of signaling pathways [13]. In consideration that
ROS has both positive and negative effect, it is conceivable that the
different intracellular redox state in different types of cell confer
themselves different redox balance, and developed different sen-
sitivity to oxidative stress or antioxidant interference, which couldnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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and cancer cells respond differently to anti-oxidative drugs.
In the present study we took normal liver cell line L02 and liver
cancer cell line SMMC-7721 as research object, trying to uncover
the reason why antioxidants inhibit cancer cells, and explore the
role played by antioxidant system and Akt signaling pathway in
regulating cancer cell's telomerase activity.2. Materials and methods
2.1. Cell culture and hypoxia exposure
L02 and SMMC-7721 cell lines were obtained from Shanghai
Institute of Cell Biology. Cells were grown in DMEM (Hyclone)
supplemented with 2 mM L-glutamine and 10% FBS in a humidi-
ﬁed incubator at 37 °C and 5% CO2. Hypoxia exposures were done
in a tri-gas tissue culture incubator (Binder) which could adjust
the oxygen concentration to 5%, 2% and 0.5%.
2.2. MTT assay
1104 cells were seeded in triplicate in a 96-well plate in a
ﬁnal volume of 100 μl and incubated for 4 h. Cells treated with
DMSO alone were used as controls. Intervention buffer (100 μl)
was then added and cultured the cells for the indicated times. At
the end of the treatment, 10 μl MTT (5 mg/ml) was added to each
well and incubated for an additional 4 h at 37 °C. DMSO (100 μl)/
well were added after dropping the old medium with MTT. The
absorbance was measured at 570 nm using a microplatereader
(Biotek Synergy 4).
2.3. GSH assay
Cells were scraped into 50 μl 1 M HPO3 and freeze/thaw for 2–3
cycles, the suspension was centrifuged with 12,000 rpm for 10 min
at 4 °C and then assayed as previously described [14].
2.4. Telomerase activity assay
Extracts of cell lines were prepared as described previously [15]
and the lysis buffer contained 10 mM Tris–HCl, pH 8.0; 1 mM
MgCl2; 1 mM EDTA; 1% (vol/vol) NP-40; 0.25 mM sodium deox-
ycholate; 10% (vol/vol) glycerol; 150 mM NaCl; 5 mM β-mercapto-
ethanol, PMSF. The extracts were quickly frozen in liquid nitrogen
and stored at 80 °C. The extracts were centrifuged at 13,000 rpm
for 30 min at 4 °C. The supernatant was used for protein quanti-
ﬁcation and the subsequent testing. Telomerase assay was done
according to the protocol previously reported [15] with some
modiﬁcation. 50 μl TRAP reaction mixture containing 2 μg cell
protein extracts, 5 μL 10 TRAP buffer, 1 μL dNTPs, 0.5 μL Phu-
sion-DNA polymerase, 1 μL TS primer (all from Thermo Scientiﬁc).
After 30 min incubation at 25 °C for TS elongation by telomerase,
the reaction was stopped by heating at 90 °C for 3 min. Then 1 μl
CX primer was added and subjected to 35 PCR cycles at 94 °C for
10 s, 50 °C for 30 s, and 72 °C for 1 min. Another 10 min at 72 °C
was needed for extention. 50 μL of PCR product was loaded and
run electrophoresis in Trisborate-EDTA on 8% polyacrylamide
nondenaturing gel. The gel was stained in low concentration of
ethidium bromide (0.5 μg/mL) for 15 min, and then photographed
under UV light.
2.5. ROS detection
For measurement of intracellular ROS, cells were harvested and
incubated with 10 μM DCFH-DA (2′-, 7′-dichloroﬂuoresceindiacetate, Sigma) for 30 min at 37 °C. Cell suspension solution was
centrifuged with 3000 rpm for 5 min, and washed twice with PBS.
The ﬂuorescence intensity was analyzed by FC 500 MCL system
(Beckman coulter) immediately at excitation/emission wavelength
of 488 nm/525 nm.
2.6. Plasmids and transfection
For overexpression of MnSOD to downregulate ROS levels, or
inhibtion of MnSOD to increase ROS level, plasmids containing
sense or antisense cDNA of human MnSOD were used. pHβ A-SOD
(þ) or pHβ A-SOD() plasmids (kindly provided by Professor
Kunitaka Hirose) were transfected into SMMC-7721 cells and es-
tablish human SMMC-7721 hepatoma cell lines with stable ex-
pression of MnSOD or with suppressed expression of MnSOD using
a standard method as described before [16].
2.7. Immunoblotting
Total cell extracts or nuclear extracts were separated by SDS-PAGE
and transferred to PVDF membranes. The following antibodies were
used for immunoblot analysis: rabbit phospho-Akt (Thr308), Akt
antibody and the PI3K inhibitor LY294002 were from Calbiochem
and secondary antibody was purchased from Proteintech. Anti-β-
actin antibody was from Cell Signaling Technology.
2.8. Statistical analysis
The results are reported as means7standard error. Statistical
signiﬁcance was determined using Student's t-test and ANOVA,
with a value of po0.05 being considered signiﬁcant.3. Results
3.1. L02 and 7721 cells need different redox state to reach their re-
spective maximum cell viability and telomerase activity
Using cell viability as the vertical axis, and using H2O2 and NAC
concentration as the horizontal axis respectively, a bell-shaped
line (as shown in Fig. 1A) could be obtained. Such curve can also be
utilized to indicate the relationship between the cellular ROS
concentration and cell viability. Interestingly, the top-points of the
bell curve of L02 and 7721 appeared at different positions, which
indicated their different sensitivity towards the exogenous ROS.
L02 cell viability reached a maximum when the concentration of
NAC was 5 mM, while the 7721 cell viability reached a maximum
when H2O2 was 5 μM.
It has been well reported that telomerase activity in normal
somatic cells was basically repressed, but are highly activated in
embryonic stem cells or tumor cells [15]. Given the close re-
lationship between telomerase activity and cell viability, we sus-
pected that telomerase activity might also represent in the form of
“bell-shaped” curve when extracellular redox state changes. As
expected, telomerase activity in L02 cells decreased with increas-
ing exogenous H2O2 concentration, but increased as NAC con-
centration was raised. However, 7721 telomerase activity, on the
contrary, declined (Fig. 1B). 7721 telomerase activity reached its
maximum value when H2O2 concentration was around 5 μM, but a
further increment in H2O2 concentration led to an inevitable de-
cline in its activity.
3.2. Moderate hypoxia-induced oxidative stress increases 7721 cells'
telomerase activity
Hypoxia is widely found in solid tumors and is the main cause
Fig. 1. Cell viability and Telomerase activity in response to NAC and H2O2 inter-
vention. (A) Cell viability of L02 and 7721 cells under NAC and H2O2 intervention.
Cells were cultured at 37 °C under 5, 10, 20, 50, 100, 150, 300 μM H2O2 or 0.5, 1, 2, 5,
10, 15, 20 mM NAC for 24 h before MTT was assayed. The arrows mark the top-
points of the bell-shaped curve which present the highest value of cell viability.
Results shown represent mean7SD, n¼3, *po0.05 vs. L02 control group,
#po0.05 vs. 7721 control group. (B) Telomerase activity of L02 (upper row) and
7721 (bottom row) cells under NAC and H2O2 intervention. Cells were cultured at
37 °C under 1, 5, 20 μM H2O2 or 1, 5, 10 mM NAC for 24 h and then quickly collected
in lysis buffer. EB-TRAP assay was conducted and the gel was photographed under
UV light. The brighter the strip is, the higher the telomerase activity is in the cell
sample tested.
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hypoxia model further veriﬁed that cancer cells preferred an oxi-
dative environment, and cells under a near-threshold redox state
held the highest telomerase activity. With the improvement in the
degree of hypoxia, ROS production in 7721 cells gradually in-
creased (Fig. 2A). The telomerase activity of 7721 cells reached its
highest value when oxygen content was reduced to 2%, but a
further decline in oxygen content (below 2%) caused telomerase
activity to decline (Fig. 2B and C).
3.3. Moderate H2O2 increases 7721 cells’ GSH/GSSG ratio
The GSH/GSSG ratio is widely used to reﬂect the intracellular
redox state and measure the cell's ability to ﬁght against oxidative
stress. We detected the GSH/GSSG ratio under different extra-
cellular redox intervention. Our results showed that 7721hepatoma cells had signiﬁcantly higher GSH/GSSG ratio than L02
liver cells (Fig. 3), which indicates that the antioxidant ability of
cancer cells is higher than that of normal cells under regular cul-
ture condition. Moderate H2O2 intervention (r1 μM) increased
the GSH/GSSG of both L02 and 7721, but with increment of H2O2
concentration, GSH/GSSG ratio of L02 declines faster compared to
that of 7721. Interestingly, GSH/GSSG level of 7721 was sig-
niﬁcantly reduced under NAC (ROS scavenger) intervention, which
implies 7721 cells require a certain amount of ROS to maintain its
GSH/GSSG level.
3.4. Endogenous ROS is involved in the regulation of 7721 cell telo-
merase activity
To investigate whether endogenous ROS was involved in the
regulation of cancer cell telomerase activity, we examined the
telomerase activity in sense/anti-sense MnSOD transfected 7721
cells. According to our results, MnSOD transfection in 7721 cells
led to a decline of intracellular ROS, whereas antisense-MnSOD
transfection increased ROS level, demonstrating the important role
played by MnSOD in antioxidant system (Fig. 4B). Similarly, telo-
merase activity was inhibited in MnSOD transfected group, but
was improved in anti-sense MnSOD transfected group (Fig. 4A).
This phenomenon indicated that ROS indeed participate in telo-
merase activity regulation.
3.5. Akt signaling pathway is involved in the regulation of 7721
telomerase activity
Akt signaling pathway regulates tumor development and sur-
vival. Phosphorylated Akt mainly participate in the anti-apoptosis
pathway, prevent PTEN-mediated cell apoptosis and keep cancer
cell alive [18]. Our previous study showed that ROS is involved in
Akt activation. We speculated that ROS may regulate telomerase
through Akt pathway [19]. As we expected, NAC intervention
signiﬁcantly reduced Akt phosphorylation in 7721 cells (Fig. 5A).
Correspondingly, H2O2 intervention increased Akt phosphoryla-
tion level in 7721, which was decreased under NAC intervention
(Supplementary Fig. 2). These results conﬁrmed that ROS indeed
activated the Akt. Either Akt phosphorylation inhibitor, LY294002,
or NAC could inhibit 7721 telomerase activity (Fig. 5B). These re-
sults suggest that ROS and Akt are both involved in upregulation of
telomerase, and likely ROS is the upstream regulator that increases
7721 telomerase activity through activating Akt.4. Discussion
Severe oxidative stress and aberrant redox control of pro-
liferation are commonly found in tumors [20], and tumor cells
apparently have developed adaptation to excessive ROS and even
beneﬁt from it. It has been reported that ROS is essential for in-
sulin secretion, however paradoxically, an excess of ROS will kill
beta cells [21]. It is proposed that the effects of ROS on cells may be
presented in the form of a bell-shaped curve, where small
amounts of ROS are signaling and very beneﬁcial, but large
amounts will cause cell damage.
It is evident that an increment in H2O2 concentration will lead
to an elevation in cellular ROS levels. The increment in NAC, also
known as ROS scavenger, may somewhat indirectly indicate a
decline in cellular ROS. In contrast to the accelerated proliferation
of L02 under moderate NAC treatment, 7721 required a little more
oxidative stress generated by H2O2 to achieve its highest viability
(Fig. 1A). We refer to the redox state when cell viability attains its
“maximum” as “the redox homeostasis threshold”. Previous stu-
dies have suggested that excessive antioxidant application will
Fig. 2. Telomerase activity and ROS level of 7721 cells under different hypoxic conditions. (A) Telomerase activity of 7721 cells under different hypoxic conditions. Cells were
cultured in a regular incubator under 21% O2 condition or a hypoxia incubator under 5%, 2% or 0.5% O2 condition for 24 h. Then the cells were collected in lysis buffer and
telomerase activity was assayed. The brighter the strip is, the higher the telomerase activity is in the cell sample tested. (B) Intracellular ROS production in 7721 cells after
incubated under 21%, 5%, 2%, 0.5% O2 condition for 24 h. Cells were collected in PBS and staining with DCF-DA before the intracellular ROS was determination by Flow
cytometry. Results shown represent mean7SD, n¼3, *po0.05 vs. control group. (C) Flow-cytometry image of 7721 cells cultured in 21% (red line), 5% (blue line), 2% (orange
line) and 0.5% (green line) O2 condition for 24 h, stained with DCF. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version
of this article.)
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production. Since the NAC concentration adopted in our model
were generally below IC50, and our results showed that such NACconcentrations signiﬁcantly inhibited intracellular ROS production
(Supplementary Fig. 1), we considered that the decline in cell
viability of L02 and 7721 at higher NAC concentration was not due
Fig. 3. GSH/GSSG ratios in L02 and 7721 cells. L02 (A) and 7721 cells (B) cultured in
1, 5, 20 μM H2O2 or 1, 5, 10 mM NAC for 24 h. GSH was assayed using OPC in pro-
tein-free extracts after GSSG reduction by DTT. Data are mean7SD for cells from at
least three independent experiments, *po0.05 vs. L02 control group, #po0.05 vs.
7721 control group.
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attributable to the lack of ROS. Preference towards NAC or H2O2
implied that an essentially different redox microenvironment was
required for cell proliferation between L02 and 7721 cells. The
redox homeostasis threshold value for 7721 cells indicated 7721
cells were more prone to be in an oxidative status as compared to
L02 cells. The results suggest that 7721 cells hold a higher redox
homeostasis threshold than L02 cells
Telomerase variation tendency of L02 and 7721 cells (Fig. 1B)
was in accord with the bell-shaped cell viability curve, indicating
that the optimal extracellular redox state for the highest telo-
merase activity in 7721 and L02 was different, and 7721 telo-
merase was inclined to favor an oxidizing microenvironment
while L02 telomerase preferred a reducing microenvironment. The
respective telomerase activity of L02 and 7721 cells reached peak
under their most appropriate redox state. This provided a theo-
retical basis for the inhibitory effect of NAC on cancer cells. Since
tumor cells “prefer” a certain degree of oxidative microenviron-
ment, whereas anti-oxidants cause tumor cells to thrive in a re-
latively reductive microenvironment, this reduces the redox state
level below their most appropriate redox state i.e. the redox
homeostasis threshold, which is not conducive to the maximum
level of telomerase activation, thereby inhibiting cell viability.
However, for normal cells, they are biased towards a reductive
environment to achieve their redox homeostasis status, therefore
NAC treatment could make the redox state closer to the threshold
of the redox homeostasis through scavenging excessive ROS,
which serves to stimulate telomerase activity and increasing cell
viability. Thus NAC selectively inhibit cancer cells’ telomerase ac-
tivity through decreasing ROS level below the redox homeostasis
threshold, but improve normal cells’ telomerase activity by low-
ering ROS level to achieve their optimal redox state (Fig. 6).
The variation tendency of telomerase activity under hypoxia
once again proves the existence of redox homeostasis threshold
and cancer cells have more preference for a moderate oxidative
microenvironment. Thus, it seems to be reasonable that NAC in-
tervention cause a decline in cancer cell telomerase activity.
Glutathione system is considered to be the cells' ﬁrst line de-
fense against extracellular ROS. Moderate H2O2 intervention in-
creased the GSH/GSSG of both L02 and 7721, but with increment ofH2O2 concentration, GSH/GSSG ratio of L02 declines faster com-
pared to that of 7721 (Fig. 3). This suggests that an appropriate
amount of H2O2 can mobilize cell's antioxidant capacity, and 7721
cells have a greater demand for H2O2 to maximize their anti-
oxidant ability. NAC is not only an ROS scavenger, but also one of
precursors of glutathione synthesis. Therefore, besides eliminating
excessive ROS, NAC could affect glutathione system and increase
GSH content theoretically. However, GSH/GSSG level of 7721 was
signiﬁcantly reduced under NAC intervention, which implies that
even though NAC could supplement cell glutathione pool, its ROS
scavenger function was overwhelming. This proves that 7721 cells
require a certain amount of ROS to maintain its GSH/GSSG level.
It was reported that moderate ROS could mobilize antioxidant
system and up-regulate cell antioxidant protection [22], which
will ultimately lead to accumulation of reducing substances (for
instance reduced glutathione) within the cell. MnSOD is one of the
most vital members of antioxidant system which is located in
mitochondria [23], and rapidly converts super oxide anion to H2O2.
Through a series of subsequent reactions, H2O2 is eventually de-
composed into H2O. MnSOD transfection accelerates ROS conver-
sion, makes more super oxide anion transform into H2O2, which
can be further decomposed to harmless water by other antioxidant
enzymes including catalase, an abundant and most powerful one.
Therefore sense-MnSOD transfection resulted in an endogenous
decreased cellular ROS level and antisens-MnSOD transfection led
to an endogenous increased cellular ROS level. Our results suggests
that endogenous ROS is involved in the regulation of 7721 cell
telomerase activity.
We have previously demonstrated that Akt phosphorylation
level is decreased in MnSOD transfected 7721 cells, but is elevated
in anti-sense MnSOD transfected ones [19,24]. Furthermore, GSH
have been reported to activate PI3K/Akt signaling and inhibit the
activation of FOXO3 [25]. Our results conﬁrmed that ROS can ac-
tivate Akt, and demonstrated that ROS-induced telomerase activity
may be correlated with Akt activation. The Akt pathway has been
shown to activate telomerase either by phosphorylation of the
hTERT subunit [26] or by both post-translational and transcrip-
tional mechanisms [27,28]. Therefore, ROS may regulate telomer-
ase activity through Akt pathway.5. Conclusion
Our results indicate that the difference of the redox home-
ostasis thresholds might be the main reason why telomerase ac-
tivities in normal cell and cancer cell are different under NAC in-
tervention. A much higher level of ROS is required for cancer cells'
growth and proliferation, which in turn results in that tumor cells
are more inclined to the oxidative redox homeostasis threshold.
NAC may remove too much ROS in tumor cells than it is supposed
to, and this affects the normal signaling transduction function
mediated by ROS such as Akt pathway, which in turn affect telo-
merase activation. Our results disclose the mechanism by which
antioxidants exerts different effects on telomerase activity of
normal and cancer cells, and suggests that optimal doses of anti-
oxidants should be used against the actual redox level in vivo. This
provides a theoretical basis for application strategy of anti-
oxidants. Findings of the present study may provide insights into
novel approaches for treatment cancer.
Fig. 4. Telomerase activity and ROS production in different cells. (A) Telomerase activity of different cells. The brighter the strip is, the higher the telomerase activity is in the
cell sample tested. (B) Intracellular ROS production in different cells. Cells were collected in PBS and staining with DCF-DA before the intracellular ROS was determination by
Flow cytometry. Results shown represent mean7SD, n¼3, *po0.05 vs. control group. (C) Flow-cytometry image of L02 (red line), 7721 cells transfected with empty
plasmids (blue line) and 7721 cells transfected with sense (orange line) or antisense (green line) MnSOD plasmids, stained with DCF. (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 5. Akt is involved in regulating telomerase activity. (A) Western blot analysis of
phosphorylated-Akt and Akt in 7721 cells under intervention of NAC (5 mM) or Akt
phosphorylation inhibitor LY294002 (20 μM) for 24 h. (B) Telomerase activity of
7721 cells under treatment of NAC (5 mM) and Akt phosphorylation inhibitor
LY294002 (20 μM) for 24 h.
Fig. 6. Cancer cells hold a higher redox homeostasis threshold than normal cells.
Under regular culture condition, the ROS level was too high for normal cells but
slightly insufﬁcient for cancer cells. NAC intervention makes the redox state closer
to the normal cell’s redox homeostasis threshold through scavenging excessive
ROS, which serves to stimulate telomerase activity and increasing cell viability. But
in cancer cells, NAC over-eliminate intracellular ROS and inhibit telomerase activity
and cell viability.
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